Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fei Li has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

  • Liesu Meng

    Department of General Surgery, Second Affiliated Hospital, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, Shaanxi, China

    5 shared publications
  • Wenhua Zhu

    Department of General Surgery, Second Affiliated Hospital, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, Shaanxi, China

    5 shared publications
  • Yan Zhou

    Department of Dermatology the First Affiliated Hospital of Xi'an Jiaotong University Xi'an China

    5 shared publications
  • Shemin Lu

    Department of General Surgery, Second Affiliated Hospital, and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, Shaanxi, China

    4 shared publications
  • Bo Wang

    Translational Medicine Center, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    3 shared publications
  • Dan Han

    Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

    3 shared publications

Latest Publications

  • Keratinocyte-derived CHI3L2 reprograms phospholipid metabolism to promote skin inflammation in psoriasis

    by Fei Li, Wentao Zhang, Wenxian Ma, Yanglong Guan, Yu Wang, Yuanyuan Cheng, Dongxia Liang, Yudan Wang, Xiangyu Xu, Leyao Feng, et al.

    Psoriasis is a chronic inflammatory skin disorder characterized by hyperproliferative keratinocytes and a dysregulated cytokine milieu, perpetuating a self-reinforcing inflammatory cycle. Despite the key involvement of keratinocytes in this pathogenic loop, the molecular pathogenesis remains incompletely understood. Here, we identify chitinase-like protein CHI3L2 as a key mediator. Elevated CHI3L2 levels were detected in serum and lesional skin from patients with psoriasis, predominantly in keratinocytes, as also verified by single-cell RNA sequencing and spatial transcriptomic analyses. In vitro stimulation of keratinocytes with M5 cytokine cocktail (IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α) increased CHI3L2 expression, demonstrating that CHI3L2 is inducible under inflammatory conditions. Transgenic mice expressing human CHI3L2 exhibited aggravated psoriasis-like phenotypes in both imiquimod- and mannan-induced psoriasis models, characterized by epidermal hyperplasia and scaling. To dissect the role of CHI3L2, we used recombinant protein injection, parabiosis, and bone marrow transplantation, identifying keratinocytes as the primary source of pathogenic CHI3L2. This was further confirmed by keratinocyte-specific CHI3L2 knockin mice. CHI3L2 functions in the HaCaT cell line and primary keratinocytes were investigated by recombinant CHI3L2 administration or CHI3L2 knockout. CHI3L2 disrupted phospholipid homeostasis, leading to altered inflammatory responses, proliferation, and differentiation of keratinocytes. CHI3L2 activated secretory phospholipase A2, elevating lysophosphatidylcholine, thereby establishing an autocrine loop perpetuating keratinocyte inflammation and reshaping the immune microenvironment. Therapeutic neutralization of CHI3L2 with antibodies or intervention of phospholipid pathway ameliorated skin inflammation in mouse psoriasis models. Our findings reveal CHI3L2 as an important regulator of keratinocyte-driven lipid remodeling and inflammation in psoriasis, highlighting potential as a therapeutic target.

  • Open Access

    Chitinase-like proteins de-N-glycosylating CD36 modify cholesterol metabolism in atherosclerotic macrophages

    by Yu Wang, Jing Zhang, Meiyang Fan, Xianbin Hou, Xiaomeng Li, Wentao Zhang, Wenbin Liu, Yue Li, Yaqi Lu, Fei Li, et al.

    Polymorphisms of mouse chitinase-like protein 3 (Chil3), a member of the mammalian chitinase-like protein (CLP) family, have been demonstrated to be associated with inflammatory diseases by regulating lipid metabolism. However, the specific immunomodulatory impacts of CLPs, mainly mouse CHIL3 and its human functional homologue chitinase-3-like 2 (CHI3L2), on macrophage cholesterol metabolism and atherosclerosis have remained unclear. Here, we find CLPs (CHIL3 and CHI3L2) accelerate atherogenesis in a macrophage-dependent manner. Mechanistically, we identify an autocrine mechanism through which CLPs regulate cholesterol metabolism in macrophages. Macrophage-secreted CLPs exacerbate lipid uptake by binding to CD36. CLPs exhibit glycosidase activity, targeting and hydrolyzing N-glycosylated glycans on CD36, predominantly at sites N220 and N321, thereby enhancing lipid uptake. Increased lipid influx activates mTOR in macrophages, driving their transition to a pro-inflammatory phenotype while simultaneously suppressing peroxisome proliferator-activated receptor gamma (PPARγ) expression and thus impairing ABCG1-mediated cholesterol efflux. Single-cell sequencing reveals that CLPs increase atherosclerotic foamy macrophages, favoring vascular smooth muscle cells (VSMC) transformation into foam and osteoblast-like cells. Additionally, neutralizing antibodies targeting CHI3L2 prevent and treat atherosclerosis. These findings highlight the potential of CLPs as targets for disease diagnosis and therapy.


  • Open Access

    Macrophagic Ym1 orchestrates γδT cell-derived IL-17 production and keratinocyte functionality to mediate psoriasis-like skin inflammation

    by Wentao Zhang, Fei Li, Yu Wang, Meiyang Fan, Yan Zhao, Yanglong Guan, Yan Zhou, Shemin Lu, Rikard Holmdahl, Liesu Meng, et al.

    Psoriasis is a chronic inflammatory skin disease, with the IL-17 pathway being a key contributor. Ym1, a positionally cloned inflammation regulatory gene linked to various disorders, has an unclear effect on skin inflammation. In this study, the role of Ym1 was investigated in both mannan and imiquimod-induced psoriasis-like dermatitis models, using Ym1-deficient congenic mice. Natural polymorphism of Ym1 influenced the development of skin inflammation, dependent on macrophages, since adoptive transferring of Ym1-deficient macrophages alleviated disease, whereas recombinant Ym1 worsened it. Particularly, Ym1 congenic mice exhibited decreased IL-17 production in innate immune cells, and depletion of γδT cells mitigated disease and lowered skin IL-17 levels. Additionally, RNA-seq analysis revealed Ym1-regulated keratinization in lesional skin. Recombination Ym1 directly influenced the inflammatory response and proliferation of mouse primary keratinocytes. Collectively, we conclude that Ym1 regulates γδT cell-derived IL-17 production and keratinocyte functionality, and thereby contributes to skin inflammation in mice.


  • IL‐21 promoting angiogenesis contributes to the development of psoriasis

    by Dan Han, Fei Li, Yan Zhao, Bo Wang, Jingyuan Wang, Bei Liu, Kuanhou Mou, Liesu Meng, Yan Zheng, Shemin Lu, et al.

    Background: Elevated IL‐21 expression which can effectively induce Th17 cell differentiation has been implicated in the pathogenesis of psoriasis, but its role in angiogenesis remains poorly understood. Methods: PASI and PSI score assessment was applied to evaluate the severity of psoriatic lesions. The expression of IL‐21, IL‐21 receptor (IL‐21R), CD31, VEGFA, MMP‐9, and ICAM‐1 in skin was determined by immunohistochemistry or quantitative real‐time polymerase chain reaction. The serum level of IL‐21 was measured by enzyme‐linked immunosorbent assay (ELISA). Then, their correlation was analyzed statistically. Human umbilical vein endothelial cells (HUVECs) cocultured with conditional medium from normal human epidermal keratinocytes (NHEKs) were treated with IL‐21 and/or M5 cocktail (mixture of IL‐1α, IL‐17A, IL‐22, TNF‐α, and oncostatin M). The migration and tube formation of HUVECs were detected, and the levels of VEGFA, MMP‐9, and ICAM‐1 in NHEKs were measured by Western blotting or ELISA. Results: Increased IL‐21 and IL‐21R expression was observed in psoriatic sera or skin specimens, with IL‐21R mainly locating in keratinocytes and IL‐21 in immune cells. Pearson analysis showed significantly positive correlation between IL‐21/IL‐21R and erythema scores/microvessel density in psoriatic lesions. Moreover, the expression of proangiogenic genes, VEGFA, ICAM‐1, and MMP‐9 was upregulated in skins of psoriasis. Additionally, in M5 microenvironment, migration and tube formation could be magnified in HUVECs using IL‐21 pre‐treated NHEK medium. Mechanically, the co‐stimulation of IL‐21 and M5 to NEHKs increased the expression of ICAM‐1. Conclusion: IL‐21 could regulate keratinocytes to secrete ICAM‐1, thereby promoting angiogenesis in psoriasis.


  • Open Access

    Multisystem Langerhans Cell Histiocytosis in Younger Infants First Presenting in Skin: A Case Series

    by Dan Han, Fei Li, Wahid H. Yahya, Rui Ge, Yan Zhao, Bei Liu, Yan Zhou, Zhuoyu Wen

    Objectives—To investigate the clinical characteristics, managements, outcome, and evaluate the risk factors of Multisystem (MS) Langerhans Cell Histiocytosis (LCH) with diverse skin lesions as the first sign in four young infants. Methods—Their clinical features, disease progression, therapy, and outcomes were reviewed and analyzed retrospectively. Results—The average onset age of skin lesions was about 2 months. Cases 1 and 2 had risk organs involved (RO+) and a lack of bone lesions, and progression could not be reversed by systemic chemotherapy. They both died eventually. Cases 3 and 4 (RO–) had bone involvement and were given systemic chemotherapy for a prolonged duration. Unluckily, Case 3 had a recurrence 2 years later, while Case 4’s recurrence happened nearly one year later, and diabetes insipidus one and a half years later. They both survived and are still in remission. Conclusion—MS-LCH infants with a low age of the first presentation in the skin are prone to dissemination, while RO+ is associated with high mortality. In addition, bone involvement may be a protective factor. Immunohistochemical examination of skin tissue facilitates correct early diagnosis, and adequate follow-up is necessary.


  • Open Access

    Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice

    by Fei Li, Dan Han, Bo Wang, Wentao Zhang, Yan Zhao, Jing Xu, Liesu Meng, Kuanhou Mou, Shemin Lu, Wenhua Zhu, et al.

    Itch is one of the major clinical manifestations of psoriasis, which is closely related with neurogenic inflammation and difficult to control. Colquhounia Root (CR) is a Chinese herb exhibiting broad bioactivities on anti-inflammation. This study was designed to explore the antipsoriatic and anti-itch potential of CR and its underlying mechanisms. Mice in a model of imiquimod-induced psoriasiform dermatitis were treated topically with CR for 7 days, and the severity of skin lesions and itch was significantly ameliorated. CR reduced the inflammatory cell infiltration, as well as mast cells in skins. Particularly, the expression of inflammatory cytokines and chemokine including Il17a, Il22, and Ccl20 and itch-related molecules such as SP, CGRP, and NGF in lesions were decreased in diseased mice upon application with CR. The normal human epidermal keratinocytes were stimulated with the M5 cytokine cocktail, the mixture of IL-17A, IL-22, Oncostatin M, IL-1α, and TNF-α, and cell viability and mRNA expression levels of inflammatory factors and itch-related molecules were measured after being treated with CR. We found that CR inhibited both cell hyperproliferation and overexpression of inflammatory cytokines and itch-related molecules in vitro. Altogether, we conclude that CR relieves psoriatic lesions and itch via controlling immunological and neurogenic inflammation.